Dr. Camille Johnson, M.D.
What this data tells you about Dr. Johnson
Dr. Camille Johnson is a hematology & oncology in Denton, TX, with 10 years in practice. Based on federal Medicare data, Dr. Johnson performed 88,117 Medicare services across 2,396 unique beneficiaries.
Between the years covered by Open Payments, Dr. Johnson received a total of $2,437 from 22 pharmaceutical and/or device companies across 55 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Johnson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 26,010 | $0 | $5 |
| Iron sucrose injection (Venofer) | 14,800 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 11,440 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 9,400 | $43 | $137 |
| Contrast dye for imaging (iodine-based) | 8,558 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) | 4,950 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $19 | $66 |
| Dexamethasone injection (steroid) | 1,150 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 870 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 570 | $1 | $114 |
| Complete blood count (CBC) with differential | 473 | $8 | $36 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 468 | $88 | $1,348 |
| Comprehensive metabolic blood panel | 466 | $10 | $64 |
| Injection, leucovorin calcium, per 50 mg | 393 | $3 | $25 |
| Blood draw (venipuncture) | 375 | $8 | $20 |
| Injection of additional new drug or substance into vein | 305 | $12 | $108 |
| Administration of chemotherapy into vein, 1 hour or less | 290 | $98 | $707 |
| Injection, fluorouracil, 500 mg | 287 | $2 | $13 |
| Injection, carboplatin, 50 mg | 278 | $2 | $300 |
| Office visit, established patient (30-39 min) | 249 | $95 | $368 |
| Drug injection, under skin or into muscle | 208 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 179 | $22 | $157 |
| Injection, potassium chloride, per 2 meq | 175 | $0 | $1 |
| Injection, magnesium sulfate, per 500 mg | 172 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 160 | $47 | $313 |
| Office visit, established patient (20-29 min) | 156 | $68 | $250 |
| Injection, zoledronic acid, 1 mg | 148 | $6 | $431 |
| Lactate dehydrogenase (enzyme) level | 116 | $6 | $31 |
| Magnesium level test | 103 | $7 | $29 |
| Ct scan of chest with contrast | 98 | $48 | $821 |
| Administration of additional new drug or substance into vein, 1 hour or less | 96 | $48 | $344 |
| Administration of chemotherapy into vein, each additional hour | 95 | $21 | $161 |
| Injection, diphenhydramine hcl, up to 50 mg | 89 | $1 | $7 |
| CT scan of abdomen and pelvis with contrast | 84 | $167 | $1,067 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 82 | $55 | $211 |
| Irrigation of implanted venous access drug delivery device | 77 | $18 | $114 |
| Ferritin level test (iron stores) | 72 | $13 | $60 |
| Iron level test | 72 | $6 | $27 |
| Iron binding capacity test | 72 | $9 | $35 |
| New patient office visit (45-59 min) | 68 | $119 | $565 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 57 | $16 | $100 |
| Injection of drug or substance into vein | 49 | $28 | $247 |
| Infusion, normal saline solution , 1000 cc | 49 | $2 | $19 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 43 | $24 | $145 |
| Administration of additional new drug or substance into vein using push technique | 41 | $42 | $289 |
| Application of on-body injector for under skin injection | 38 | $14 | $96 |
| Initial hospital admission, moderate complexity | 29 | $100 | $470 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 29 | $1 | $19 |
| Infusion into a vein for hydration, 31-60 minutes | 25 | $25 | $256 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 25 | $272 | $2,762 |
| Reticulated (young) platelet measurement | 24 | $35 | $143 |
| Microscopic examination for white blood cells with manual cell count | 22 | $4 | $22 |
| Complete blood count (CBC), automated | 22 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 21 | $15 | $94 |
| Hospital follow-up visit, low complexity | 21 | $38 | $135 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 21 | $1 | $17 |
| CT scan of chest, without contrast | 19 | $44 | $686 |
| Red blood count automated, with additional calculations | 14 | $5 | $26 |
| Infusion into a vein for hydration, each additional hour | 14 | $10 | $75 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Johnson is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Johnson experienced with iron infusion (feraheme)?
Does Dr. Johnson receive payments from pharmaceutical companies?
How do Dr. Johnson's costs compare to other hematology & oncologys in Denton?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology